Nusano News

dGenThera and Nusano Sign Letter of Intent for Astatine‑211 Supply

Alpha-emitting radioisotope expected to play an essential role in next-generation targeted cancer therapies DURHAM, N.C. and WEST VALLEY CITY, Utah – June 19, 2025 –...

Nusano and Atomiq Collaborating to Develop Nuclear Battery Technologies

Feb 24, 2025

WEST VALLEY CITY, Utah – Feb. 24, 2025 – Nusano, a physics company transforming the production of radioisotopes, and Atomiq, Inc., a cutting-edge nuclear battery technologies subsidiary of Kronos Advanced Technologies, today announced a collaboration agreement to...

Nusano Named Researcher of the Year at Inaugural Best of BioHive Awards

Feb 21, 2025

[dsm_image_carousel gallery_ids="292288,292284,292285,292287,292286,292280" sizes="thumbnail" lazyload="on" centered_slides="on" autoplay_speed="4000" show_lightbox="on" _builder_version="4.27.4" _module_preset="default" global_colors_info="{}"...

Nusano to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference

Feb 7, 2025

WEST VALLEY CITY, Utah – Feb. 7, 2025 – Nusano, a physics company transforming the production of radioisotopes, today announced the company’s CFO Pushkar Bedekar will present at Oppenheimer’s 35th Annual Healthcare Life Sciences Conference on Tuesday, February 11,...

Nusano to Present at Piper Sandler Next-Gen RadioPharma Symposium

Jan 22, 2025

VALENCIA, Calif. – Jan. 22, 2025 – Nusano, a physics company transforming the production of radioisotopes, today announced the company’s CEO Chris Lowe will present at Piper Sandler’s Nex-Gen RadioPharma Symposium virtual event on Thursday, Jan. 23, 2025. The fireside...

Nusano and Caspian Studios Announce Launch of Talk Radioisotopes Podcast

Jan 22, 2025

Premier episode available today across all podcast platformsVALENCIA, Calif. – Jan. 22, 2025 – Nusano, a physics company transforming the production of radioisotopes, and Caspian Studios, an award-winning content-as-a-service studio, today announced the launch of the...

Nusano and Atley Solutions in Collaboration to Accelerate Astatine-211 Development

Jan 16, 2025

Nusano isotope production to deliver breakthrough, 100X increase in global At-211 supply, and Atley’s radiopharmaceutical manufacturing technology to enable scalable At-211 radiopharmaceutical supplyVALENCIA, Calif. and GOTHENBURG, Sweden – Jan. 16, 2025 – Nusano, a...

Nusano Announces Isotope Availability

Jan 10, 2025

High-volume, breakthrough radioisotope production platform to enable innovation in life sciences and industrial applications VALENCIA, Calif. – January 10, 2025 – Nusano, a privately held physics company transforming the production of radioisotopes utilized in...

Nusano to Host Virtual KOL Panel Discussion on December 17, 2024 Previewing the Year Ahead in Radioligand Therapy (RLT)

Dec 11, 2024

VALENCIA, Calif. – Dec. 11, 2024 – Nusano, a physics company transforming the production of radioisotopes, today announced it will host a virtual key opinion leader (KOL) panel discussion on Tuesday, December 17, 2024 at 1:00 PM ET to preview the year ahead in...

Nusano and GlyTherix Announce Lutetium-177 Supply Agreement

Dec 9, 2024

VALENCIA, Calif. and SYDNEY, Australia – Dec. 9, 2024 – Nusano, a physics company transforming the production of radioisotopes, and GlyTherix Ltd (GlyTherix) an Australian targeted radiotherapy company specializing in developing antibody radiopharmaceuticals for solid...